Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger L, Koenig J, Galle PR. Moehler M, et al. BMC Cancer. 2016 Aug 31;16(1):699. doi: 10.1186/s12885-016-2736-9. BMC Cancer. 2016. PMID: 27582078 Free PMC article. Clinical Trial.
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
Behling F, Fodi C, Gepfner-Tuma I, Kaltenbach K, Renovanz M, Paulsen F, Skardelly M, Honegger J, Tatagiba M; International Consortium on Meningiomas; Schittenhelm J, Tabatabai G. Behling F, et al. Among authors: gepfner tuma i. Neuro Oncol. 2021 Aug 2;23(8):1273-1281. doi: 10.1093/neuonc/noaa303. Neuro Oncol. 2021. PMID: 33367841 Free PMC article.
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G. Tzaridis T, et al. Neuro Oncol. 2019 Jul 11;21(7):954-955. doi: 10.1093/neuonc/noz071. Neuro Oncol. 2019. PMID: 31089718 Free PMC article. No abstract available.
Integrative assessment of brain and bone invasion in meningioma patients.
Zwirner K, Paulsen F, Schittenhelm J, Gepfner-Tuma I, Tabatabai G, Behling F, Skardelly M, Bender B, Zips D, Eckert F. Zwirner K, et al. Among authors: gepfner tuma i. Radiat Oncol. 2019 Jul 29;14(1):132. doi: 10.1186/s13014-019-1341-x. Radiat Oncol. 2019. PMID: 31358024 Free PMC article. Clinical Trial.
Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas.
Schittenhelm J, Krischker N, Gepfner-Tuma I, Behling F, Noell S, Eckert F, Biskup S, Tabatabai G. Schittenhelm J, et al. Brain Pathol. 2019 May;29(3):321-324. doi: 10.1111/bpa.12709. Epub 2019 Feb 1. Brain Pathol. 2019. PMID: 30676672 Free PMC article. No abstract available.
18 results